Merran Findlay, AdvAPD of The University of Sydney, Sydney, Australia, discusses her view on patient nutrition during early stages of…
Browsing: Acute Lymphoblastic Leukemia
Charles Loprinzi, MD of Mayo Clinic, Rochester, MN gives an overview of neuropathy risk factors and discusses new data showing…
Merran Findlay, AdvAPD of The University of Sydney, Sydney, Australia, explains that a diagnosis of head and neck cancer typically…
Gregory Crawford, MBBS, MPHC, MD, FRACGP, FAChPM of The University of Adelaide, Adelaide, Australia discusses the importance of understanding patients…
Merran Findlay, AdvAPD of The University of Sydney, Sydney, Australia, discusses patient care and access to specialist dietitians. Specialist dietitians…
Jervoise Andreyev, MA, PhD, FRCP of The Royal Marsden NHS Foundation Trust, London, United Kingdom discusses the need for a…
Merran Findlay, AdvAPD of The University of Sydney, Sydney, Australia, discusses clinical guidelines and available literature on patient care from…
James Larkin, MD, PhD, of the Royal Marsden NHS Foundation Trust, London, UK, discusses the highlights in melanoma from the…
James Larkin, MD, PhD, of the Royal Marsden NHS Foundation Trust, London, UK, discusses aggressive melanoma, which he considers to…
Sharon Liberali, BDS (Adel), DClinDent (FICD, FPFA, FRACDS) of Adelaide Dental Hospital, Adelaide, Australia, discusses the role of dentist in…
Sharon Liberali, BDS (Adel), DClinDent (FICD, FPFA, FRACDS) of Adelaide Dental Hospital, Adelaide, Australia, emphasizes the importance of the treatment…
Gregory Crawford, MBBS, MPHC, MD, FRACGP, FAChPM of The University of Adelaide, Adelaide, Australia discusses a session organised by the…
James Larkin, MD, PhD, of the Royal Marsden NHS Foundation Trust, London, UK, discusses the session Clinical problems in oncology…
Karen Mustian, PhD, MPH, ACSM of the University of Rochester Medical Center, Rochester, New York, NY gives a brief overview…
James Larkin, MD, PhD, of the Royal Marsden NHS Foundation Trust, London, UK, explains the treatment options available for patients…
Thomas Powles, MD, PhD from Barts Cancer Institute, London, UK discusses the BISCAY clinical trial in bladder cancer (NCT02546661). The…
Martin Reck, MD, PhD of the LungenClinic Grosshansdorf, Grosshansdorf, Germany, highlights the importance of the randomized Phase III JAVELIN Lung…
James Larkin, MD, PhD, of the Royal Marsden NHS Foundation Trust, London, UK, discusses the upcoming Melanoma Patient Conference in…
Eleni Efstathiou, MD, PhD of the University of Texas MD Anderson Cancer Center, Houston, Texas, TX, provides an overview of…
Anas Younes, MD of Memorial Sloan Kettering Cancer Center, New York, NY talks about how social media can give you…
Anas Younes, MD of Memorial Sloan Kettering Cancer Center, New York, NY talks about the iwNHL 2016 meeting that will…
Karen Mustian, PhD, MPH, ACSM of the University of Rochester Medical Center, Rochester, New York, NY, discusses various fatigue dimensions…
Sharon Liberali, BDS (Adel), DClinDent (FICD, FPFA, FRACDS) of Adelaide Dental Hospital, Adelaide, Australia, emphasises the importance of dentists during…
Charles Loprinzi, MD from Mayo Clinic, Rochester, MN discusses neurotoxicities caused by a chemotherapy treatment. Numbness, tingling, shooting, and burning…
Karen Mustian, PhD, MPH, ACSM of the University of Rochester Medical Center, Rochester, New York, NY, discusses advantages of using…
Karen Mustian, PhD, MPH, ACSM of the University of Rochester Medical Center, Rochester, New York, NY, discusses the importance of…
Mark Schubert, DDS, MSD of Seattle Care Alliance, Seattle, WA provides an overview of his journey through plasmacytoma treatment. With…
Rachel Gibson, PhD of University of South Australia, Adelaide, Australia highlights the 25th anniversary of MASCC in Adelaide, Australia. MASCC…
Mark Schubert, DDS, MSD of Seattle Care Alliance Seattle, WA discusses what he as a dental clinician has learnt through…
Dr. Luke Peppone of University of Rochester Medical Center, Rochester, NY discusses results from a preliminary study measuring omega 3…
Rachel Gibson, PhD of University of South Australia, Adelaide, Australia explores the links between chemotherapy induced toxicities that would normally…
In this Ask the Expert segment, Dr. Gareth Morgan of UAMS Myeloma Institute answers a question from Patient Power viewer,…
In this presentation from the ESMO 18th World Congress on Gastrointestinal Cancer, Dr. Bertram Wiedenmann discusses the clinician’s contribution to…
In this presentation from the ESMO 18th World Congress on Gastrointestinal Cancer, Dr. Christophe Deroose discusses the contribution of isotopic…
In this presentation from the ESMO 18th World Congress on Gastrointestinal Cancer, Dr. Timm Denecke discusses the contribution of CT…
In this presentation from the ESMO 18th World Congress on Gastrointestinal Cancer, Dr. Florian Lordick discusses new agents on the…
In this presentation from the ESMO 18th World Congress on Gastrointestinal Cancer, Dr. Andrés Cervantes discusses the impact of targeting…
In this presentation from the ESMO 18th World Congress on Gastrointestinal Cancer, Dr. William H. Allum provides the surgeon’s perspective…
In this presentation from the ESMO 18th World Congress on Gastrointestinal Cancer, Dr. March Ychou provides the EU perspective on…
In this Keynote Lecture, Dr. Adam Bass examines the taxonomy in gastric cancer.
In this presentation from the ESMO 18th World Congress on Gastrointestinal Cancer, Dr. Fátima Carneiro discusses the pathologist’s perspective on…
In this presentation from the ESMO 18th World Congress on Gastrointestinal Cancer, Dr. David H. Ilson examines which is the…
Thomas Powles, MD, PhD from Barts Cancer Institute, London, UK discusses key points of a new Phase III clinical trial…
Sumanta Pal, MD of City of Hope, Duarte, CA, discusses the introduction of new data of the new single-agent cabozantinib…
Press brief by Philip Mack, PhD of the UC Davis Comprehensive Cancer Center, Sacramento, CA, at the 2016 Annual Meeting…
Paolo Ascierto, MD, of the National Tumor Institute Fondazione G. Pascale, Naples, Italy, discusses the safety of nivolumab for advanced…
James Larkin, MD, PhD, of the Royal Marsden NHS Foundation Trust, London, UK, discusses the next steps for the treatment…
Erika Hamilton of Sarah Cannon Research Institute, Nashville, TN talks about a Phase I trial of ONT-380 in combination with…
David Ross Camidge, MD, PhD of the University of Colorado, Denver, CO, provides an insight into emibetuzumab, a monoclonal antibody…
What is phlebotomy, and how will it help my polycythemia vera (PV)? Patient Power Founder and Host, Andrew Schorr,, discusses…